Drugmakers Stand Up for Reproductive Rights: Pfizer and Biogen Among 300 Condemning Abortion Pill Approval Suspension
Last week Friday, a U.S. judge suspended the FDA's approval of mifepristone, effectively banning sales. Executives from over 300 companies, including Pfizer Inc (NYSE: PFE) and Biogen Inc (NASDAQ: BIIB), signed an open letter calling to reverse a federal judge's decision. The abortion pill has…
#fda #pfizerinc #pfe #biogeninc